Upgrade to SI Premium - Free Trial

TD Cowen on Medtronic, Inc. (MDT): 'Buy; We Expect Solid F2Q Results'

November 14, 2025 8:57 AM
TD Cowen analyst Joshua Jennings reiterated a Buy rating and $106.00 price target on Medtronic, Inc. (NYSE: MDT).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles